General Information of Drug (ID: DMW9CH2)

Drug Name
Tetramethylbutylphenol Drug Info
Synonyms
P-T-Octylphenol; Phenol, p-(tert-octyl)-; p-Octylphenol (VAN); p-Terc.oktylfenol; p-terc.Oktylfenol [Czech]; p-tert-Octylphenol; para-tert-Octylphenol; 4-(1,1,3,3-Tetramethylbutyl)phenol; tert-Octylphenol, flaked; 140-66-9; 4-(1,1,3,3-TETRAMETHYLBUTYL)PHENOL; 4-(2,4,4-trimethylpentan-2-yl)phenol; 4-(TERT-OCTYL)PHENOL; 4-t-Octylphenol; 4-tert-Octylphenol; BRN 0513992; EINECS 205-426-2; HSDB 5411; NSC 5427; Phenol, 4-(1,1,3,3-tetramethylbutyl)-; Phenol, p-(1,1,3,3-tetramethylbutyl)-; IOY9FVU3J3; UNII-IOY9FVU3J3; p-(1,1,3,3-Tetramethylbutyl)phenol
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
8814
ChEBI ID
CHEBI:34445
CAS Number
CAS 140-66-9
TTD Drug ID
DMW9CH2
INTEDE Drug ID
DR1983

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Drug(s) Metabolized By Sulfotransferase 2A1 (SULT2A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [2]
Abiraterone acetate DMANBZI Prostate cancer 2C82.0 Approved [3]
Pregnenolone DM6VFO1 Schizophrenia 6A20 Phase 4 [4]
Vonoprazan DMCOJPS Gastro-oesophageal reflux DA22 Phase 4 [5]
Asp-015K DMZ1UOI Psoriasis vulgaris EA90 Phase 3 [6]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [2]
BCP-13498 DM2BO9W Anaesthesia 9A78.6 Phase 2 [7]
Daidzein DMRFTJX Discovery agent N.A. Investigative [2]
Bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [2]
N-nonylphenol DMH3OUX Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Sulfotransferase 2A1 (SULT2A1) Main DME DE0P6LK ST2A1_HUMAN Substrate [2]

References

1 Insights into virus inactivation by polysorbate 80 in the absence of solvent. Biotechnol Prog. 2019 Dec 17:e2953.
2 Sulfation of environmental estrogens by cytosolic human sulfotransferases. Drug Metab Pharmacokinet. 2002;17(3):221-8.
3 Abiraterone for the treatment of metastatic castrate-resistant prostate cancer. Ann Pharmacother. 2012 Jul-Aug;46(7-8):1016-24.
4 Expression and characterization of the human 3 beta-hydroxysteroid sulfotransferases (SULT2B1a and SULT2B1b). J Steroid Biochem Mol Biol. 2001 Jun;77(4-5):261-9.
5 In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker. Xenobiotica. 2017 Dec;47(12):1027-1034.
6 Human mass balance, metabolite profile and identification of metabolic enzymes of [14C]ASP015K, a novel oral janus kinase inhibitor. Xenobiotica. 2015;45(10):887-902.
7 Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects. Birth Defects Res A Clin Mol Teratol. 2008 Mar;82(3):155-65.